Thus, this study aimed to determine whether GHRH antagonists of MIA class enhance the antitumor effects of IR in vitro, in NSCLC cell lines and primary NSCLC cells, as well as to elucidate the underlying molecular mechanisms. Here, GHRH is linked to non-small cell lung carcinoma.